NCT05797623

Safety and Effectiveness of Trappa Ethanolamine Tablets Combined With Ciclosporin in the Treatment of Primary Treatment of Non-severe Aplastic Anemia

A Multicenter, Randomized, Double-blind, and Open-label, Placebo-controlled Phase II Clinical Study of Trappa Ethanolamine Tablets Combined With Ciclosporin in Patients With Treatment of Non-severe Aplastic Anemia

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 78 (estimated)
• Sponsor: Jiangsu HengRui Medicine Co., Ltd. · Industry
• Sex: All
• Age: 14 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This is a multicenter, randomized, double-blind, and open-label, placebo-controlled phase II clinical study. In order to evaluate the effectiveness and safety of trappa ethanolamine tablets combined with ciclosporin in the treatment of patients with non-severe aplastic anemia.

Conditions

• Non-severe Aplastic Anemia

Interventions

Type	Name	Description
DRUG	Trappa ethanolamine tablets ; ciclosporin	Trappa ethanolamine tablets combined with ciclosporin
DRUG	Placebo ; ciclosporin	Placebo combined with ciclosporin

Timeline

• Start date: 2023-04-26
• Primary completion: 2024-05-30
• Completion: 2025-05-30
• First posted: 2023-04-04
• Last updated: 2023-09-01

Locations

1 site across 1 country: China